Advertisement

High-Grade Salivary Gland Tumors: Salivary Duct Carcinoma, High-Grade Mucoepidermoid Carcinoma, and Carcinoma ex Pleomorphic Adenoma

  • William C. Faquin
  • Celeste N. Powers
Part of the Essentials in Cytopathology Series book series (EICP, volume 5)

High-grade salivary gland tumors are extremely important to recognize in FNA samples. In contrast to benign and low-grade salivary gland neoplasms, which are managed conservatively, the diagnosis of a high-grade salivary gland tumor will usually result in an aggressive clinical response that can include radical surgical resection, nerve sacrifice, lymph node dissection, and chemoradiation therapy. Among the more common high-grade salivary gland cancers that will be discussed in this chapter are salivary duct carcinoma, high-grade mucoepidermoid carcinoma, and carcinoma ex pleomorphic adenoma. With regard to impact on clinical management, the primary goal is to diagnose the tumor as a “high-grade carcinoma,” rather than focusing on the specific subtype of high-grade carcinoma. As will be discussed in more detail, this is fortunate, since there is significant cytologic overlap between the 3 major high-grade salivary gland tumors. Other even rarer high-grade salivary gland malignancies that can be encountered include primary squamous cell carcinoma, small cell carcinoma, undifferentiated carcinoma, and certain metastatic cancers.

Keywords

Salivary Gland Parotid Gland Pleomorphic Adenoma Merkel Cell Carcinoma Salivary Gland Tumor 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Boahene DK, Olsen KD, Lewis JE, et al. Mucoepidermoid carcinoma of the parotid gland: the Mayo Clinic experience. Arch Otolaryngol Head Neck Surg 2004;130:849–856.PubMedCrossRefGoogle Scholar
  2. Etges A, Pinto DS, Kowalski LP et al. Salivary duct carcinoma: immunohistochemical profile of an aggressive salivary gland tumor. J Clin Pathol 2003;56:914–918.PubMedCentralPubMedCrossRefGoogle Scholar
  3. Fowler MH, Fowler J, Ducatman B, Barnes L, Hunt JL. Malignant mixed tumors of the salivary gland: a study of loss of heterozygosity in tumor suppressor genes. Mod Pathol 2006;19:350–355.PubMedCrossRefGoogle Scholar
  4. Henke AC, Cooley ML, Hughes JH, Timmerman TG. Fine-needle aspiration cytology of small-cell carcinoma of the parotid. Diagn Cytopathol 2001;25:126–129.PubMedCrossRefGoogle Scholar
  5. Henley JD, Geary WA, Jackson CL, Wu CD, Gnepp DR. Dedifferentiated acinic cell carcinoma of the parotid gland: a distinct rarely described entity. Hum Pathol 1997;28:869–873.PubMedCrossRefGoogle Scholar
  6. Hocwald E, Korkmaz H, Yoo GH, et al. Prognostic factors in major salivary gland tumors. Laryngoscope 2001;111:1434.PubMedCrossRefGoogle Scholar
  7. Nagao T, Gaffey TA, Olsen KD, Serizawa H, Lewis JE. Small cell carcinoma of the major salivary glands: clinicopathologic study with emphasis on cytokeratin 20 immunoreactivity and clinical outcome. Am J Surg Pathol 2004;28:762–770.PubMedCrossRefGoogle Scholar
  8. Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors: frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol 2003;119:801–806.PubMedCrossRefGoogle Scholar
  9. Nigam S, Kumar N, Jain S. Cytomorphologic spectrum of carcinoma ex pleomorphic adenoma. Acta Cytol 2004;48:309–314.PubMedCrossRefGoogle Scholar
  10. Skalova A, Starek I, Vanecek T, et al. Expression of HER-2/neu gene and protein in salivary duct carcinomas of parotid gland as revealed by fluorescence in-situ hybridization and immunohistochemistry. Histopathol 2003;42:348–356.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2008

Authors and Affiliations

  • William C. Faquin
    • 1
  • Celeste N. Powers
    • 2
  1. 1.Department of Pathology, Massachusetts General HospitalHarvard Medical SchoolBostonUSA
  2. 2.Department of Pathology, Medical College of Virginia HospitalsVirginia Commonwealth UniversityRichmondUSA

Personalised recommendations